Our analysis revealed increased CD45+ immune cells (~2-3 fold) and among CD45+ cells, a significant increase only in T cells but not in B cells, NK cells, mast cells, or macrophages in the tumor samples compared to STM (Figure 1B). This evidence concerns the gene PTPRC and neoplasm.